Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Irving D. Kaplan, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Stuver R, Faig J, Cadorette M, Decaneas W, Kaplan I, VanDeWege C, Weden V, Kent M, Zerillo JA. Survivorship Care Plans: Reaching a Benchmark and Striving to Achieve Intent. JCO Oncol Pract. 2020 Jul 29; OP2000092. PMID: 32726174.
    Citations:    
  2. Siva S, Correa RJM, Warner A, Staehler M, Ellis RJ, Ponsky L, Kaplan ID, Mahadevan A, Chu W, Gandhidasan S, Swaminath A, Onishi H, Teh BS, Lo SS, Muacevic A, Louie AV. Stereotactic Ablative Radiotherapy for =T1b Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Int J Radiat Oncol Biol Phys. 2020 Jun 17. PMID: 32562838.
    Citations:    
  3. Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S. Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print]. Eur Urol Focus. 2019 Oct 31. PMID: 31679868.
    Citations:    
  4. Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Nov; 5(6):958-969. PMID: 31248849.
    Citations:    
  5. Correa RJM, Louie AV, Staehler M, Warner A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh BS, Lo SS, Muacevic A, Siva S. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK. J Urol. 2019 06; 201(6):1097-1104. PMID: 30741849.
    Citations:    
  6. Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. JAMA Netw Open. 2019 02 01; 2(2):e188006. PMID: 30735235.
    Citations:    
  7. Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA. Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):287-295. PMID: 29913254.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  8. Meier RM, Bloch DA, Cotrutz C, Beckman AC, Henning GT, Woodhouse SA, Williamson SK, Mohideen N, Dombrowski JJ, Hong RL, Brachman DG, Linson PW, Kaplan ID. Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):296-303. PMID: 30191864.
    Citations:    Fields:    Translation:Humans
  9. Mihalcik SA, Chipman JJ, Sanda MG, Regan MM, Kaplan ID, Wagner AA, Crociani CM, Chang P. Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP. Pract Radiat Oncol. 2018 Nov - Dec; 8(6):445-451. PMID: 29935957.
    Citations:    Fields:    Translation:Humans
  10. Siva S, Louie AV, Warner A, Muacevic A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh B, Correa RJ, Lo SS, Staehler M. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Cancer. 2018 03 01; 124(5):934-942. PMID: 29266183.
    Citations: 1     Fields:    
  11. Chang P, Regan MM, Ferrer M, Guedea F, Patil D, Wei JT, Hembroff LA, Michalski JM, Saigal CS, Litwin MS, Hamstra DA, Kaplan ID, Ciezki JP, Klein EA, Kibel AS, Sandler HM, Dunn RL, Crociani CM, Sanda MG. Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. J Urol. 2017 02; 197(2):376-384. PMID: 27593476.
    Citations: 1     Fields:    Translation:Humans
  12. Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, Garin O, Ferrer M, Hamstra DA, Spratt DE. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):770-777. PMID: 27663760.
    Citations: 1     Fields:    Translation:Humans
  13. Lischalk JW, Kaplan ID, Collins SP. Stereotactic Body Radiation Therapy for Localized Prostate Cancer. Cancer J. 2016 Jul-Aug; 22(4):307-13. PMID: 27441752.
    Citations: 1     Fields:    Translation:Humans
  14. Sun MR, Brook A, Powell MF, Kaliannan K, Wagner AA, Kaplan ID, Pedrosa I. Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. AJR Am J Roentgenol. 2016 Mar; 206(3):544-53. PMID: 26901010.
    Citations: 1     Fields:    Translation:Humans
  15. Schoenfeld JD, Mahadevan A, Floyd SR, Dyer MA, Catalano PJ, Alexander BM, McDermott DF, Kaplan ID. Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review. J Immunother Cancer. 2015; 3:50. PMID: 26672895.
    Citations: 16     Fields:    
  16. Evans JR, Zhao S, Daignault S, Sanda MG, Michalski J, Sandler HM, Kuban DA, Ciezki J, Kaplan ID, Zietman AL, Hembroff L, Feng FY, Suy S, Skolarus TA, McLaughlin PW, Wei JT, Dunn RL, Finkelstein SE, Mantz CA, Collins SP, Hamstra DA. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiother Oncol. 2015 Aug; 116(2):179-84. PMID: 26276528.
    Citations: 7     Fields:    Translation:Humans
  17. Buch K, Morancy T, Kaplan I, Qureshi MM, Hirsch AE, Rofksy NM, Holupka E, Oismueller R, Hawliczek R, Helbich TH, Bloch BN. Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resonance imaging: a feasibility study. J Contemp Brachytherapy. 2015 Jan; 6(4):337-43. PMID: 25834576.
    Citations: 3     
  18. Talcott JA, Manola J, Chen RC, Clark JA, Kaplan I, D'Amico AV, Zietman AL. Using patient-reported outcomes to assess and improve prostate cancer brachytherapy. BJU Int. 2014 Oct; 114(4):511-6. PMID: 24112602.
    Citations: 1     Fields:    Translation:Humans
  19. Brenner MJ, Kaplan ID. Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer? J Clin Oncol. 2014 Jun 10; 32(17):1851-2. PMID: 24778396.
    Citations: 2     Fields:    Translation:Humans
  20. Aizer AA, Paly JJ, Michaelson MD, Rao SK, Nguyen PL, Kaplan ID, Niemierko A, Olumi AF, Efstathiou JA. Medical oncology consultation and minimization of overtreatment in men with low-risk prostate cancer. J Oncol Pract. 2014 Mar; 10(2):107-12. PMID: 24399853.
    Citations: 3     Fields:    Translation:Humans
  21. Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Models of care and NCCN guideline adherence in very-low-risk prostate cancer. J Natl Compr Canc Netw. 2013 Nov; 11(11):1364-72. PMID: 24225970.
    Citations: 4     Fields:    Translation:Humans
  22. King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, Meier R, Wang J, Kupelian P, Steinberg M, Katz A. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol. 2013 Nov; 109(2):217-21. PMID: 24060175.
    Citations: 84     Fields:    Translation:HumansCTClinical Trials
  23. Hamstra DA, Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban DA, Wei JT, Sanda MG, Michalski JM. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. Int J Radiat Oncol Biol Phys. 2013 Jul 01; 86(3):546-53. PMID: 23561651.
    Citations: 9     Fields:    Translation:Humans
  24. Bubley GJ, Bloch BN, Vazquez C, Genega E, Holupka E, Rofsky N, Kaplan I. Accuracy of endorectal magnetic resonance/transrectal ultrasound fusion for detection of prostate cancer during brachytherapy. Urology. 2013 Jun; 81(6):1284-9. PMID: 23490527.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  25. Katz AJ, Freeman D, Kaplan ID, Fuller DB, Bolzicco G, Collins SP, Meier R, Wang J, King CR. Long-term efficacy of stereotactic body radiotherapy for localized prostate cancer: A multi-institutional pooled analysis. J Clin Oncol. 2013 Feb 20; 31(6_suppl):9. PMID: 28137157.
    Citations:    
  26. Paly JJ, Zietman AL, Nguyen PL, Beard C, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Multidisciplinary care and management of very low-risk prostate cancer. J Clin Oncol. 2013 Feb 20; 31(6_suppl):55. PMID: 28137047.
    Citations:    
  27. Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol. 2012 Sep 01; 30(25):3071-6. PMID: 22851571.
    Citations: 24     Fields:    Translation:Humans
  28. Aizer A, Paly JJ, Zietman AL, D'Amico AV, Nguyen PL, Beard C, Rao SK, Kaplan ID, Hirsch MS, Wu CL, Efstathiou JA. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):131. PMID: 28143227.
    Citations:    
  29. McBride SM, Wong DS, Dombrowski JJ, Harkins B, Tapella P, Hanscom HN, Collins SP, Kaplan ID. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. Cancer. 2012 Aug 01; 118(15):3681-90. PMID: 22170628.
    Citations: 60     Fields:    Translation:HumansCTClinical Trials
  30. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14. PMID: 21934053.
    Citations: 59     Fields:    Translation:HumansPHPublic Health
  31. Talcott JA, Zietman AL, Kaplan ID, Clark JA, D'Amico AV. Does prostate brachytherapy that avoids the central zone prevent long-term urinary incontinence? Five-year results of a multi-institutional comparative cohort study. J Clin Oncol. 2011 May 20; 29(15_suppl):4665. PMID: 28023888.
    Citations:    
  32. Hurwitz MD, Hansen JL, Prokopios-Davos S, Manola J, Wang Q, Bornstein BA, Hynynen K, Kaplan ID. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153. Cancer. 2011 Feb 01; 117(3):510-6. PMID: 20886629.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  33. Kamo N, Dandapani SV, Miksad RA, Houlihan MJ, Kaplan I, Regan M, Greenfield TK, Sanda MG. Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet. Ann Oncol. 2011 Mar; 22(3):723-729. PMID: 20716625.
    Citations: 13     Fields:    Translation:Humans
  34. Sanda MG, Kaplan ID. A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatment. JAMA. 2009 May 27; 301(20):2141-51. PMID: 19417179.
    Citations: 6     Fields:    Translation:Humans
  35. Sommers BD, Beard CJ, D'Amico AV, Kaplan I, Richie JP, Zeckhauser RJ. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer. 2008 Oct 15; 113(8):2058-67. PMID: 18704993.
    Citations: 27     Fields:    Translation:Humans
  36. Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, Wong ET, La Rosa S, Wang F, Berman SM. Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):281-9. PMID: 18406892.
    Citations: 12     Fields:    Translation:Humans
  37. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008 Mar 20; 358(12):1250-61. PMID: 18354103.
    Citations: 486     Fields:    Translation:Humans
  38. Petit JH, Gluck C, Kiger WS, Henry DL, Karasiewicz C, Talcott J, Berg S, Holupka E, Kaplan I. Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. Urol Oncol. 2008 Jul-Aug; 26(4):372-7. PMID: 18367113.
    Citations: 4     Fields:    Translation:Humans
  39. Sommers BD, Beard CJ, D'Amico AV, Dahl D, Kaplan I, Richie JP, Zeckhauser RJ. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer. Cancer. 2007 Nov 15; 110(10):2210-7. PMID: 17893907.
    Citations: 20     Fields:    Translation:Humans
  40. Petit JH, Gluck C, Kiger WS, Laury Henry D, Karasiewicz C, Talcott JA, Berg S, Holupka EJ, Kaplan ID. Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume. Brachytherapy. 2007 Oct-Dec; 6(4):267-71. PMID: 17959423.
    Citations: 1     Fields:    Translation:Humans
  41. Bloch BN, Lenkinski RE, Helbich TH, Ngo L, Oismueller R, Jaromi S, Kubin K, Hawliczek R, Kaplan ID, Rofsky NM. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):70-8. PMID: 17513062.
    Citations: 10     Fields:    Translation:Humans
  42. Miksad RA, Bubley G, Church P, Sanda M, Rofsky N, Kaplan I, Cooper A. Prostate cancer in a transgender woman 41 years after initiation of feminization. JAMA. 2006 Nov 15; 296(19):2316-7. PMID: 17105793.
    Citations: 4     Fields:    Translation:Humans
  43. Kaplan ID, Meskell P, Oldenburg NE, Saltzman B, Kearney GP, Holupka EJ. Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy. 2006 Jul-Sep; 5(3):147-51. PMID: 16864065.
    Citations: 10     Fields:    Translation:Humans
  44. Miksad RA, Bubley G, Church P, Cooper A, Rofsky N, Kaplan I, Sanda M. Analysis of hormonal receptor status in tissue from prostate cancer that developed 26 years after bilateral orchiectomy and following 41 years of estrogen therapy. J Clin Oncol. 2006 Jun 20; 24(18_suppl):14610. PMID: 27954489.
    Citations:    
  45. Bues M, Holupka EJ, Meskell P, Kaplan ID. Effect of random seed placement error in permanent transperineal prostate seed implant. Radiother Oncol. 2006 Apr; 79(1):70-4. PMID: 16515813.
    Citations: 2     Fields:    Translation:Humans
  46. Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia. 2005 Nov; 21(7):649-56. PMID: 16278168.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  47. Talcott JA, Clark JA, Manola J, Zietman AL, Kaplan I, D'Amico AV, Coen J, Mitchell SP, Reilly CE. Using patient-reported outcomes to assess prostate brachytherapy technique. J Clin Oncol. 2005 Jun; 23(16_suppl):4697. PMID: 27946876.
    Citations:    
  48. Kiger WS, Lu XQ, Harling OK, Riley KJ, Binns PJ, Kaplan J, Patel H, Zamenhof RG, Shibata Y, Kaplan ID, Busse PM, Palmer MR. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam. Appl Radiat Isot. 2004 Nov; 61(5):1075-81. PMID: 15308195.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  49. Holupka EJ, Meskell PM, Burdette EC, Kaplan ID. An automatic seed finder for brachytherapy CT postplans based on the Hough transform. Med Phys. 2004 Sep; 31(9):2672-9. PMID: 15487750.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  50. Holupka EJ, Meskell PM, Kaplan ID. Automatic detection of linear artifacts in medical images. Med Phys. 2004 Sep; 31(9):2707-10. PMID: 15487754.
    Citations:    Fields:    Translation:Humans
  51. Tay MH, Kaufman DS, Regan MM, Leibowitz SB, George DJ, Febbo PG, Manola J, Smith MR, Kaplan ID, Kantoff PW, Oh WK. Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. Ann Oncol. 2004 Jun; 15(6):974-8. PMID: 15151957.
    Citations: 8     Fields:    Translation:Humans
  52. Seo PH, D'Amico AV, Clark JA, Kaplan I, Manola JB, Mitchell SP, Talcott JA. Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment? Clin Prostate Cancer. 2004 Jun; 3(1):38-42. PMID: 15279689.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  53. Kaplan ID, Meskell PM, Lieberfarb M, Saltzman B, Berg S, Holupka EJ. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial. Brachytherapy. 2004; 3(1):7-9. PMID: 15110307.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  54. Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003 Nov 01; 21(21):3979-86. PMID: 14581420.
    Citations: 34     Fields:    Translation:Humans
  55. Giaid A, Lehnert SM, Chehayeb B, Chehayeb D, Kaplan I, Shenouda G. Inducible nitric oxide synthase and nitrotyrosine in mice with radiation-induced lung damage. Am J Clin Oncol. 2003 Aug; 26(4):e67-72. PMID: 12902901.
    Citations: 11     Fields:    Translation:AnimalsPHPublic Health
  56. Oh WK, Manola J, Bittmann L, Brufsky A, Kaplan ID, Smith MR, Kaufman DS, Kantoff PW. Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up. Urology. 2003 Jul; 62(1):99-104. PMID: 12837431.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  57. Oh WK, Kaplan ID, Febbo P, Prisby J, Manola J, Kaufman DS, Kantoff PW. Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity. Am J Clin Oncol. 2003 Jun; 26(3):312-6. PMID: 12796607.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  58. Busse PM, Harling OK, Palmer MR, Kiger WS, Kaplan J, Kaplan I, Chuang CF, Goorley JT, Riley KJ, Newton TH, Santa Cruz GA, Lu XQ, Zamenhof RG. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol. 2003 Mar-Apr; 62(1-2):111-21. PMID: 12749707.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  59. Coleman CN, Kelly L, Riese Daly N, Beard C, Kaplan I, Lamb C, Propert K, Manola J. Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects. Int J Radiat Oncol Biol Phys. 2002 Sep 01; 54(1):191-4. PMID: 12182991.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  60. Ben-Josef E, Han S, Tobi M, Shaw LM, Bonner HS, Vargas BJ, Prokop S, Stamos B, Kelly L, Biggar S, Kaplan I. A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1160-4. PMID: 12128116.
    Citations: 13     Fields:    Translation:Humans
  61. Hurwitz MD, Schnieder L, Manola J, Beard CJ, Kaplan ID, D'Amico AV. Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1106-10. PMID: 12128108.
    Citations: 4     Fields:    Translation:Humans
  62. Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia. Int J Radiat Oncol Biol Phys. 2002 Jul 15; 53(4):913-8. PMID: 12095557.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  63. Kaplan I, Oldenburg NE, Meskell P, Blake M, Church P, Holupka EJ. Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging. 2002 Apr; 20(3):295-9. PMID: 12117612.
    Citations: 34     Fields:    Translation:Humans
  64. Das P, Kaplan I. The role of PC-SPES, selenium, and vitamin E in prostate cancer. Oncology (Williston Park). 2002 Mar; 16(3):285-91; discussion 291, 295-6, 299-300. PMID: 15046388.
    Citations:    Fields:    Translation:Humans
  65. Ben-Josef E, Han S, Tobi M, Vargas BJ, Stamos B, Kelly L, Biggar S, Kaplan I. Intrarectal application of amifostine for the prevention of radiation-induced rectal injury. Semin Radiat Oncol. 2002 Jan; 12(1 Suppl 1):81-5. PMID: 11917290.
    Citations: 12     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  66. D'Amico AV, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001 Mar 01; 49(3):679-84. PMID: 11172949.
    Citations: 5     Fields:    Translation:Humans
  67. Hurwitz MD, Kaplan ID, Svensson GK, Hynynen K, Hansen MS. Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer. Int J Hyperthermia. 2001 Jan-Feb; 17(1):31-7. PMID: 11212878.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  68. Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst. 2000 Dec 06; 92(23):1918-25. PMID: 11106683.
    Citations: 95     Fields:    Translation:HumansCells
  69. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer. Prostate Cancer Prostatic Dis. 2000 Dec; 3(4):259-264. PMID: 12497074.
    Citations: 1     Fields:    
  70. D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA. 2000 Sep 13; 284(10):1280-3. PMID: 10979115.
    Citations: 27     Fields:    Translation:Humans
  71. Kaplan ID, Holupka EJ, Meskell P, Soon SJ, Saltzman B, Church P, Kearney GP. Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer. Urology. 2000 Sep 01; 56(3):492-5. PMID: 10962322.
    Citations: 2     Fields:    Translation:Humans
  72. Kaplan I. Minimizing rectal and urinary complications in prostate brachytherapy. J Endourol. 2000 May; 14(4):381-3. PMID: 10910156.
    Citations: 1     Fields:    Translation:Humans
  73. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer. Mol Urol. 2000; 4(3):171-5;discussion 177. PMID: 11062371.
    Citations: 2     Fields:    Translation:Humans
  74. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res. 1999 Sep 01; 59(17):4291-6. PMID: 10485474.
    Citations: 155     Fields:    Translation:HumansCells
  75. D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999 Jan; 17(1):168-72. PMID: 10458230.
    Citations: 66     Fields:    Translation:Humans
  76. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998 Sep 16; 280(11):969-74. PMID: 9749478.
    Citations: 767     Fields:    Translation:Humans
  77. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A. Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy. J Clin Oncol. 1998 Sep; 16(9):3094-100. PMID: 9738580.
    Citations: 4     Fields:    Translation:Humans
  78. Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 1998 May 01; 41(2):257-62. PMID: 9607338.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  79. D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Wein A, Tomaszewski JE, Coleman CN. Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter. Cancer. 1998 Jan 15; 82(2):334-41. PMID: 9445191.
    Citations: 1     Fields:    Translation:Humans
  80. Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol. 1998 Jan; 16(1):275-83. PMID: 9440753.
    Citations: 27     Fields:    Translation:Humans
  81. D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. Int J Radiat Oncol Biol Phys. 1997 Sep 01; 39(2):335-40. PMID: 9308936.
    Citations: 3     Fields:    Translation:Humans
  82. Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao P, Chang C, Loda M. Heterogeneity of androgen receptor content in advanced prostate cancer. Mod Pathol. 1997 Aug; 10(8):839-45. PMID: 9267828.
    Citations: 19     Fields:    Translation:Humans
  83. Brufsky A, Fontaine-Rothe P, Berlane K, Rieker P, Jiroutek M, Kaplan I, Kaufman D, Kantoff P. Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate. Urology. 1997 Jun; 49(6):913-20. PMID: 9187700.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  84. D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, Wein A, Coleman CN. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. Int J Radiat Oncol Biol Phys. 1997 Mar 15; 37(5):1053-8. PMID: 9169812.
    Citations: 9     Fields:    Translation:Humans
  85. Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest. 1997 Jan; 76(1):37-51. PMID: 9010448.
    Citations: 39     Fields:    Translation:HumansCells
  86. Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, Talcott JA. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol. 1997 Jan; 15(1):223-9. PMID: 8996146.
    Citations: 21     Fields:    Translation:Humans
  87. Holupka EJ, Kaplan ID, Burdette EC, Svensson GK. Ultrasound image fusion for external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Jul 15; 35(5):975-84. PMID: 8751406.
    Citations:    Fields:    Translation:Humans
  88. D'Amico AV, Kaplan I. Select transition zone prostate cancers may be radiocurable despite markedly elevated prostate-specific antigen levels. Radiother Oncol. 1996 Jan; 38(1):73-6. PMID: 8850429.
    Citations:    Fields:    Translation:Humans
  89. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol. 1994 Dec; 12(12):2634-9. PMID: 7527455.
    Citations: 20     Fields:    Translation:HumansCells
  90. Kaplan ID, Cox RS, Bagshaw MA. Radiotherapy for prostatic cancer: patient selection and the impact of local control. Urology. 1994 May; 43(5):634-9. PMID: 8165765.
    Citations:    Fields:    Translation:Humans
  91. Kaplan ID, Castro JR, Phillips TL. Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory. Int J Radiat Oncol Biol Phys. 1994 Jan 01; 28(1):257-61. PMID: 8270449.
    Citations: 4     Fields:    Translation:Humans
  92. Cox RS, Kaplan ID, Bagshaw MA. Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1994 Jan 01; 28(1):23-31. PMID: 7505773.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  93. Beard CJ, Kaplan ID, Coleman CN. The challenge for conformal therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1993 Jul 15; 26(4):705-7. PMID: 8331005.
    Citations:    Fields:    Translation:Humans
  94. Coleman CN, Kaplan ID. Prostate cancer. Technology versus biology. Cancer. 1993 Jul 15; 72(2):305-9. PMID: 7686440.
    Citations: 1     Fields:    Translation:Humans
  95. Kaplan ID, Cox RS, Bagshaw MA. Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. J Urol. 1993 Mar; 149(3):519-22. PMID: 7679756.
    Citations: 3     Fields:    Translation:Humans
  96. Bagshaw MA, Kaplan ID, Cox RC. Prostate cancer. Radiation therapy for localized disease. Cancer. 1993 Feb 01; 71(3 Suppl):939-52. PMID: 8428344.
    Citations: 10     Fields:    Translation:Humans
  97. Kaplan ID, Adler JR, Hicks WL, Fee WE, Goffinet DR. Radiosurgery for palliation of base of skull recurrences from head and neck cancers. Cancer. 1992 Oct 01; 70(7):1980-4. PMID: 1525775.
    Citations: 3     Fields:    Translation:Humans
  98. Kaplan ID, Bagshaw MA. Serum prostate-specific antigen after post-prostatectomy radiotherapy. Urology. 1992 May; 39(5):401-6. PMID: 1374576.
    Citations: 3     Fields:    Translation:Humans
  99. Kaplan ID, Prestidge BR, Bagshaw MA, Cox RS. The importance of local control in the treatment of prostatic cancer. J Urol. 1992 Mar; 147(3 Pt 2):917-21. PMID: 1538497.
    Citations: 5     Fields:    Translation:Humans
  100. Bagshaw MA, Kaplan ID, Valdagni R, Cox RS. Radiation treatment of prostate bone metastases and the biological considerations. Adv Exp Med Biol. 1992; 324:255-68. PMID: 1283500.
    Citations: 1     Fields:    Translation:Humans
  101. Fuller BG, Kaplan ID, Adler J, Cox RS, Bagshaw MA. Stereotaxic radiosurgery for brain metastases: the importance of adjuvant whole brain irradiation. Int J Radiat Oncol Biol Phys. 1992; 23(2):413-8. PMID: 1375218.
    Citations: 21     Fields:    Translation:Humans
  102. Kaplan ID, Bagshaw MA, Cox CA, Cox RS. External beam radiotherapy for incidental adenocarcinoma of the prostate discovered at transurethral resection. Int J Radiat Oncol Biol Phys. 1992; 24(3):415-21. PMID: 1399725.
    Citations:    Fields:    Translation:Humans
  103. Kaplan ID, Cox RS, Bagshaw MA. A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy. Cancer. 1991 Jul 15; 68(2):400-5. PMID: 1712665.
    Citations: 3     Fields:    Translation:Humans
  104. Kaplan ID, Valdagni R, Cox RS, Bagshaw MA. Reduction of spinal metastases after preemptive irradiation in prostatic cancer. Int J Radiat Oncol Biol Phys. 1990 May; 18(5):1019-25. PMID: 2347712.
    Citations: 3     Fields:    Translation:Humans
  105. Stevens SK, Moore SG, Kaplan ID. Early and late bone-marrow changes after irradiation: MR evaluation. AJR Am J Roentgenol. 1990 Apr; 154(4):745-50. PMID: 2107669.
    Citations: 18     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kaplan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (314)
Explore
_
Co-Authors (50)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.